These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy. Oliveira-Santos A; Dagda M; Burkin DJ Hum Mol Genet; 2022 Jul; 31(14):2358-2369. PubMed ID: 35157045 [TBL] [Abstract][Full Text] [Related]
57. Urine titin as a novel biomarker for Duchenne muscular dystrophy. Ishii MN; Nakashima M; Kamiguchi H; Zach N; Kuboki R; Baba R; Hirakawa T; Suzuki K; Quinton M Neuromuscul Disord; 2023 Apr; 33(4):302-308. PubMed ID: 36871413 [TBL] [Abstract][Full Text] [Related]
58. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419 [TBL] [Abstract][Full Text] [Related]
59. Dual AAV Gene Therapy for Duchenne Muscular Dystrophy with a 7-kb Mini-Dystrophin Gene in the Canine Model. Kodippili K; Hakim CH; Pan X; Yang HT; Yue Y; Zhang Y; Shin JH; Yang NN; Duan D Hum Gene Ther; 2018 Mar; 29(3):299-311. PubMed ID: 28793798 [TBL] [Abstract][Full Text] [Related]
60. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways. Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]